Skip to main content
Premium Trial:

Request an Annual Quote

Too Expensive

Premium

Cancer care is expensive — that's certainly not a new concept. But a new report commissioned by Lancet Oncology shows just how expensive and unaffordable care is becoming, reports Reuters' Kate Kelland. An "explosion" of new technology and drugs, combined with rising rates of the disease, mean that patients are becoming less and less able to pay for the latest life-saving advances, she adds. The report says there should be a shift in thinking to ensure treatments are priced fairly, and that new technologies add tangible value to the cancer research field. "The cost of new cancer cases is already estimated to be about $286 billion a year, with medical costs making up more than half the economic burden and productivity losses account for nearly a quarter, according to Economist Intelligence United data cited in the report," Kelland says. "The report, led by Richard Sullivan of Britain's King's Health Partners Integrated Cancer Centre in London, said policy-makers, doctors, patients groups and the health industry should work together to find ways to stem future cost rises."

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.